These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 12297362

  • 41. Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program.
    Johnson DM, Sader HS, Fritsche TR, Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2003 Sep; 47(1):373-6. PubMed ID: 12967753
    [Abstract] [Full Text] [Related]

  • 42. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.
    Sahm DF, Brown NP, Thornsberry C, Jones ME.
    Postgrad Med; 2008 Sep; 120(3 Suppl 1):16-24. PubMed ID: 18931467
    [Abstract] [Full Text] [Related]

  • 43. Surveillance on susceptibility of strains isolated from pediatric infections.
    Sakata H, Watanabe A, Iwata S, Sato Y, Suzuki K, Miyashita N, Hori S, Yamaguchi Y, Odajima M, Katakuse Y, Hasegawa T, Maki N, Wada K.
    J Infect Chemother; 2019 Mar; 25(3):163-169. PubMed ID: 30600131
    [Abstract] [Full Text] [Related]

  • 44. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA, Farrell DJ, Sader HS, Jones RN.
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [Abstract] [Full Text] [Related]

  • 45. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
    Johnson DM, Biedenbach DJ, Beach ML, Pfaller MA, Jones RN.
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):99-105. PubMed ID: 10863104
    [Abstract] [Full Text] [Related]

  • 46. Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756.
    Bell JM, Turnidge JD, Jones RN, SENTRY Regional Participants Group.
    Int J Antimicrob Agents; 2002 Feb; 19(2):125-32. PubMed ID: 11850165
    [Abstract] [Full Text] [Related]

  • 47. The in vitro effects of faropenem on lower respiratory tract pathogens isolated in the United Kingdom.
    Walsh F, Amyes AK, Amyes SG.
    Int J Antimicrob Agents; 2003 Jun; 21(6):581-4. PubMed ID: 12791474
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000.
    Critchley IA, Blosser-Middleton R, Jones ME, Yamakita J, Aswapokee N, Chayakul P, Tharavichitukul P, Vibhagool A, Thornsberry C, Karlowsky JA, Sahm DF.
    J Chemother; 2002 Apr; 14(2):147-54. PubMed ID: 12017369
    [Abstract] [Full Text] [Related]

  • 50. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ, Giménez MJ, Barberán J, Coronel P, Gimeno M, Aguilar L.
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [Abstract] [Full Text] [Related]

  • 51. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan.
    Inoue M, Kohno S, Kaku M, Yamaguchi K, Igari J, Yamanaka K.
    Int J Infect Dis; 2005 Jan; 9(1):27-36. PubMed ID: 15603993
    [Abstract] [Full Text] [Related]

  • 52. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey.
    Gonullu N, Catal F, Kucukbasmaci O, Ozdemir S, Torun MM, Berkiten R.
    Chemotherapy; 2009 Jan; 55(3):161-7. PubMed ID: 19390189
    [Abstract] [Full Text] [Related]

  • 53. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in Taiwan.
    Lau YJ, Hsueh PR, Liu YC, Shyr JM, Huang WK, Teng LJ, Liu CY, Luh KT.
    Microb Drug Resist; 2006 Jan; 12(2):130-5. PubMed ID: 16922631
    [Abstract] [Full Text] [Related]

  • 54. Antimicrobial resistance of respiratory pathogens isolated from pediatric patients.
    Zarakolu P, Unal S.
    J Chemother; 2006 Oct; 18(5):565-6. PubMed ID: 17127238
    [No Abstract] [Full Text] [Related]

  • 55. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA.
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-1992.
    Gómez J, Ruiz-Gómez J, Hernández-Cardona JL, Núñez ML, Canteras M, Valdés M.
    Chemotherapy; 1994 Nov; 40(5):299-303. PubMed ID: 7956452
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.
    Thornsberry C, Ogilvie PT, Holley HP, Sahm DF.
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2612-23. PubMed ID: 10543737
    [Abstract] [Full Text] [Related]

  • 60. The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004.
    Melo-Cristino J, Santos L, Ramirez M, Grupo de Estudo Português de Bactérias Patogénicas Respiratórias.
    Rev Port Pneumol; 2006 Nov; 12(1):9-30. PubMed ID: 16572254
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.